시장보고서

상품코드

1514926

치료용 단백질 및 경구 백신 시장 : 치료용 단백질 유형별, 전달 방법별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type, By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 06월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 393 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

치료용 단백질 및 경구 백신 시장 규모는 2023년 2억 5,145만 달러로 2024년부터 2032년까지 연평균 7.9% 성장할 것으로 예상됩니다.

치료용 단백질 및 경구 백신 시장 - 시장 역학

개인맞춤형 의료와 손쉬운 예방이 치료용 단백질 및 경구 백신 시장의 성장을 견인

치료용 단백질 및 경구 백신을 이용한 개인 맞춤형 의료와 간편한 예방 전략이 헬스케어 시장의 활황에 박차를 가하고 있습니다. 미국 암학회 데이터에 따르면, 맞춤형 단백질 치료제인 CAR-T 세포 치료는 일부 백혈병에서 80%의 완치율을 보이고 있습니다. 또한, 2023년 세계보건기구(WHO) 보고서에 따르면, 경구 백신은 사용 편의성으로 인해 개발도상국의 아동기 예방접종률을 20%까지 향상시킬 수 있다고 합니다. 이러한 개인 맞춤형 치료와 편리한 예방법의 결합은 치료용 단백질 및 경구 백신 분야에 대한 막대한 투자를 촉진하고 시장 성장을 촉진하고 있습니다.

치료용 단백질 및 경구 백신 시장 - 주요 인사이트

당사의 리서치 애널리스트들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 7.9%의 CAGR로 성장할 것으로 예상됩니다.

치료용 단백질 유형별 부문에서는 단클론항체가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

전달 방법별로는 2023년 주사가 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

치료용 단백질 및 경구 백신 시장 - 세분화 분석:

세계 치료용 단백질 및 경구 백신 시장은 치료용 단백질 유형, 전달 방법, 용도 및 지역에 따라 세분화됩니다.

치료용 단백질 시장은 치료용 단백질의 종류에 따라 단클론항체, 효소, 성장인자, 인터페론, 인터류킨, 백신 등 6가지 카테고리로 나뉩니다. 단클론항체는 다양한 암과 자가면역질환을 치료하기 위한 표적화된 접근법으로 인해 치료용 단백질 부문을 지배하고 있습니다. 효소는 대사성 질환의 치료제로 주목받고 있으며, 성장 인자는 조직 재생에 유망한 치료제로 주목받고 있습니다. 인터페론과 인터류킨은 면역 조절의 가능성을 보여주고 있으며, 백신, 특히 경구 백신은 예방의학에 혁명을 일으키고 있습니다.

시장은 전달 방법에 따라 주사제, 흡입제, 외용제 등 세 가지 범주로 나뉩니다. 주사는 정확한 용량 관리와 효과로 인해 여전히 치료용 단백질 전달 방법의 주류로 남아 있습니다. 흡입은 호흡기 질환 치료에 널리 사용되고 있으며, 국소 적용은 국소 치료의 편리함을 제공합니다.

치료용 단백질 및 경구 백신 시장 - 지리적 인사이트

북미는 높은 의료비, 만성질환의 증가, 잘 구축된 연구 인프라 등의 요인으로 인해 가장 높은 점유율을 차지하고 있습니다. 그러나 아시아태평양은 가처분 소득의 증가, 정부의 헬스케어 정책, 환자 수 증가 등으로 인해 빠르게 성장하고 있습니다. 바이오의약품 개발에 주력하고 있는 유럽은 꾸준한 성장을 지속하고 있는 성숙한 시장입니다. 아프리카와 라틴아메리카의 신흥국들은 의료 수요가 충족되지 않고 정부의 의료 투자가 확대되고 있기 때문에 큰 잠재력을 가지고 있습니다. 이 시장에서 기업의 성공 여부는 지역 규제를 잘 극복하고, 다양한 경제 환경에 맞는 가격 전략을 개발하고, 광범위한 접근성을 보장하기 위한 파트너십을 구축할 수 있는지에 달려 있습니다.

치료용 단백질 및 경구 백신 시장 - 경쟁 상황:

치료용 단백질 및 경구 백신 시장은 암젠, 화이자, 존슨앤드존슨과 같은 대형 제약회사들이 경쟁하는 시장입니다. 이들 기업들은 풍부한 R&D 예산을 활용하여 혁신적인 치료제와 경구 백신을 개발하기 위해 노력하고 있습니다. 인수합병도 전략적인 움직임 중 하나이며, 예를 들어 화이자는 겸상적혈구 치료제 분야의 선도기업을 인수한 바 있습니다. 또한, 유망한 틈새 솔루션을 보유한 중소 바이오테크 기업들도 등장하고 있어 역동적인 환경이 조성되고 있습니다. 이들 기업과 학계 및 정부 기관과의 협력은 연구개발을 가속화하기 위해 필수적입니다. 기존 단백질 치료제를 대체할 수 있는 비용 효율적인 대안을 제시하는 바이오시밀러에 대한 관심이 높아지면서 경쟁은 더욱 치열해지고 있습니다. 이는 가격 책정에 대한 압박을 가할 뿐만 아니라, 각 회사들에게 끊임없는 기술 혁신과 제품 차별화를 요구하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 치료용 단백질 및 경구 백신 업계

경쟁 대시보드
기업 개요
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Eli Lilly and Company
- Emergent Biosolutions Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Lumen Bioscience Inc.
- Merck &Co., Inc.
- MigVax Ltd
- Neurelis Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- TransAlgae
- Others

제12장 애널리스트의 전방위 전망

ksm 24.07.24

REPORT HIGHLIGHT

Therapeutic Proteins and Oral Vaccines Market size was valued at USD 251.45 Million in 2023, expanding at a CAGR of 7.9% from 2024 to 2032.

The Therapeutic Proteins and Oral Vaccines market encompasses treatments utilizing proteins and convenient oral vaccines. This growth is fueled by the rising need for these therapies, particularly in cancer, diabetes, and infectious diseases. Increased clinical trials, advancements in protein engineering, and growing government support for research are propelling the market forward. However, high manufacturing costs and stringent regulatory hurdles pose challenges. Despite these, the potential for personalized medicine using therapeutic proteins and the growing demand for needle-free vaccination present exciting market opportunities.

Therapeutic Proteins and Oral Vaccines Market- Market Dynamics

Personalized Medicine & Easy Prevention Drive Therapeutic Protein & Oral Vaccine Market Growth

Personalized medicine and easy prevention strategies using therapeutic proteins and oral vaccines are fueling a boom in the healthcare market. American Cancer Society data shows CAR-T cell therapy, a personalized protein treatment, achieving an 80% remission rate in some leukemias. Furthermore, a 2023 World Health Organization report suggests oral vaccines could raise childhood immunization rates in developing countries by 20% due to their user-friendliness. This confluence of personalized treatments and convenient preventative methods is driving substantial investment and propelling market growth within the Therapeutic Protein and Oral Vaccine sectors.

Therapeutic Proteins and Oral Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.9% over the forecast period (2024-2032)

Based on Therapeutic Protein Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Injections were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Therapeutic Proteins and Oral Vaccines Market- Segmentation Analysis:

The Global Therapeutic Proteins and Oral Vaccines Market is segmented based on Therapeutic Protein Type, Delivery Method, Application, and Region.

The market is divided into six categories based on Therapeutic Protein Type: Monoclonal Antibodies, Enzymes, Growth Factors, Interferons, Interleukins, and Vaccines. Monoclonal antibodies dominate the therapeutic protein segment due to their targeted approach to treating various cancers and autoimmune diseases. Enzymes are gaining traction for metabolic disorders, while growth factors hold promise in tissue regeneration. Interferons and interleukins show potential in immunomodulation, and vaccines, especially oral ones, are revolutionizing preventative care.

The market is divided into three categories based on Delivery Method: Injection, Inhalation, and Topical application. Injections remain the dominant delivery method for therapeutic proteins due to precise dosage control and effectiveness. Inhalation is gaining traction for respiratory diseases, while topical applications offer convenience for localized treatment.

Therapeutic Proteins and Oral Vaccines Market- Geographical Insights

North America holds the highest share due to factors like high healthcare expenditure, rising chronic disease prevalence, and established research infrastructure. However, regions like Asia Pacific are experiencing rapid growth fueled by increasing disposable income, government healthcare initiatives, and a large patient population. Europe, with its strong focus on biopharmaceutical development, presents a mature market with steady growth. Developing countries in Africa and Latin America offer significant potential due to unmet medical needs and growing government investments in healthcare. The success of companies in this market will depend on their ability to navigate regional regulations, develop pricing strategies that cater to varying economic landscapes, and establish partnerships to ensure wider accessibility.

Therapeutic Proteins and Oral Vaccines Market- Competitive Landscape:

The Therapeutic Proteins and Oral Vaccines market is a competitive arena with established pharmaceutical giants like Amgen, Pfizer, and Johnson & Johnson vying for dominance. These players leverage their extensive R&D budgets to develop innovative therapies and oral vaccines. Mergers and acquisitions are another strategic move, for instance, Pfizer's acquisition of a leading sickle cell therapy company. Additionally, smaller biotechnology firms are emerging with promising niche solutions, fostering a dynamic environment. Collaboration between these players, with academic institutions and government agencies, is crucial for accelerating research and development. The competitive landscape is further intensified by the growing focus on biosimilars, which offer cost-effective alternatives to established protein therapies. This not only puts pressure on pricing but also compels companies to constantly innovate and differentiate their products.

Recent Developments:

In January 2022, Amgen Inc., a biotechnology company, and Generate Biomedicines, a drug generation company, announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across various disease areas.

In November 2022, Merck & Co., Inc. announced that it would acquire Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms, for approximately USD 1.35 billion. Imago's lead candidate, bomedemstat, is an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor currently being evaluated in multiple Phase 2 clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories

Amgen Inc.

Biogen Inc.

Eli Lilly and Company

Emergent Biosolutions Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson

Lumen Bioscience Inc.

Merck & Co., Inc.

MigVax Ltd

Neurelis Inc.

Novo Nordisk A/S

Pfizer Inc.

Sanofi S.A.

Serum Institute of India Pvt. Ltd.

TransAlgae

Others

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY THERAPEUTIC PROTEIN TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Enzymes
Growth Factors
Interferons
Interleukins
Vaccines

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

Injection
Inhalation
Topical application

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Metabolic Disorders
Other Diseases

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Therapeutic Proteins and Oral Vaccines Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Therapeutic Proteins and Oral Vaccines Market Snippet by Therapeutic Protein Type
- 2.1.2. Therapeutic Proteins and Oral Vaccines Market Snippet by Delivery Method
- 2.1.3. Therapeutic Proteins and Oral Vaccines Market Snippet by Application
- 2.1.4. Therapeutic Proteins and Oral Vaccines Market Snippet by Country
- 2.1.5. Therapeutic Proteins and Oral Vaccines Market Snippet by Region
2.2. Competitive Insights

3. Therapeutic Proteins and Oral Vaccines Key Market Trends

3.1. Therapeutic Proteins and Oral Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Proteins and Oral Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Proteins and Oral Vaccines Market Opportunities
3.4. Therapeutic Proteins and Oral Vaccines Market Future Trends

4. Therapeutic Proteins and Oral Vaccines Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Therapeutic Proteins and Oral Vaccines Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Therapeutic Proteins and Oral Vaccines Market Landscape

6.1. Therapeutic Proteins and Oral Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Therapeutic Proteins and Oral Vaccines Market - By Therapeutic Protein Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutic Protein Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Enzymes
- 7.1.4. Growth Factors
- 7.1.5. Interferons
- 7.1.6. Interleukins
- 7.1.7. Vaccines

8. Therapeutic Proteins and Oral Vaccines Market - By Delivery Method

8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
- 8.1.2. Injection
- 8.1.3. Inhalation
- 8.1.4. Topical application

9. Therapeutic Proteins and Oral Vaccines Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Autoimmune Diseases
- 9.1.4. Infectious Diseases
- 9.1.5. Neurological Disorders
- 9.1.6. Metabolic Disorders
- 9.1.7. Other Diseases

10. Therapeutic Proteins and Oral Vaccines Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Therapeutic Proteins and Oral Vaccines Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Amgen Inc.
- 11.2.3. Biogen Inc.
- 11.2.4. Eli Lilly and Company
- 11.2.5. Emergent Biosolutions Inc.
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.7. Johnson & Johnson
- 11.2.8. Lumen Bioscience Inc.
- 11.2.9. Merck & Co., Inc.
- 11.2.10. MigVax Ltd
- 11.2.11. Neurelis Inc.
- 11.2.12. Novo Nordisk A/S
- 11.2.13. Pfizer Inc.
- 11.2.14. Sanofi S.A.
- 11.2.15. Serum Institute of India Pvt. Ltd.
- 11.2.16. TransAlgae
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us